Medikaloka Hermina Tbk PT
IDX:HEAL
Wall Street
Price Targets
HEAL Price Targets Summary
Medikaloka Hermina Tbk PT
According to Wall Street analysts, the average 1-year price target for
HEAL
is 1 742.16 IDR
with a low forecast of 1 414 IDR and a high forecast of 2 047.5 IDR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HEAL's stock price target?
Price Target
1 742.16
IDR
According to Wall Street analysts, the average 1-year price target for
HEAL
is 1 742.16 IDR
with a low forecast of 1 414 IDR and a high forecast of 2 047.5 IDR.
What is Medikaloka Hermina Tbk PT's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Medikaloka Hermina Tbk PT's revenue is
15%.
The projected
CAGR
for the next 3 years is
11%.
What is Medikaloka Hermina Tbk PT's Operating Income forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Medikaloka Hermina Tbk PT's operating income is
16%.
The projected
CAGR
for the next 3 years is
10%.
What is Medikaloka Hermina Tbk PT's Net Income forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Medikaloka Hermina Tbk PT's net income is
31%.
The projected
CAGR
for the next 3 years is
12%.
